Page last updated: 2024-11-10

dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium: RN given refers to bromide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035249
SCHEMBL ID5275687
MeSH IDM0082979

Synonyms (16)

Synonym
(2-hydroxy-5-nitrobenzyl)dimethylsulphonium bromide
28611-73-6
AKOS024319155
dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium bromide
dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium
sulfonium, ((2-hydroxy-5-nitrophenyl)methyl)dimethyl-, bromide (1:1)
sulfonium, ((2-hydroxy-5-nitrophenyl)methyl)dimethyl-, bromide
einecs 249-105-5
FT-0638789
sulfonium, [(2-hydroxy-5-nitrophenyl)methyl]dimethyl-, bromide
SCHEMBL5275687
J-017158
(2-hydroxy-5-nitrobenzyl)dimethylsulfonium bromide
(2-hydroxy-5-nitrophenyl)methyl-dimethylsulfanium;bromide
DTXSID20885437
sulfonium, [(2-hydroxy-5-nitrophenyl)methyl]dimethyl-, bromide (1:1)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (52.38)18.7374
1990's7 (33.33)18.2507
2000's2 (9.52)29.6817
2010's1 (4.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.20 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]